TESSENDERLO GROUP (TESB.BR) Stock Fundamental Analysis

EBR:TESB • BE0003555639

26.3 EUR
-0.6 (-2.23%)
Last: Mar 2, 2026, 07:00 PM
Fundamental Rating

4

Overall TESB gets a fundamental rating of 4 out of 10. We evaluated TESB against 66 industry peers in the Chemicals industry. TESB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TESB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year TESB has reported negative net income.
  • In the past year TESB had a positive cash flow from operations.
  • In the past 5 years TESB has always been profitable.
  • In the past 5 years TESB always reported a positive cash flow from operatings.
TESB.BR Yearly Net Income VS EBIT VS OCF VS FCFTESB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

  • TESB has a Return On Assets of -0.96%. This is in the lower half of the industry: TESB underperforms 66.67% of its industry peers.
  • With a Return On Equity value of -1.52%, TESB is not doing good in the industry: 65.15% of the companies in the same industry are doing better.
  • TESB has a Return On Invested Capital of 2.47%. This is comparable to the rest of the industry: TESB outperforms 51.52% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TESB is in line with the industry average of 6.96%.
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROIC 2.47%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
TESB.BR Yearly ROA, ROE, ROICTESB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • In the last couple of years the Profit Margin of TESB has declined.
  • Looking at the Operating Margin, with a value of 2.61%, TESB is in line with its industry, outperforming 40.91% of the companies in the same industry.
  • In the last couple of years the Operating Margin of TESB has declined.
  • TESB's Gross Margin of 19.33% is on the low side compared to the rest of the industry. TESB is outperformed by 71.21% of its industry peers.
  • TESB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.61%
PM (TTM) N/A
GM 19.33%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
TESB.BR Yearly Profit, Operating, Gross MarginsTESB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TESB is destroying value.
  • Compared to 1 year ago, TESB has less shares outstanding
  • The number of shares outstanding for TESB has been increased compared to 5 years ago.
  • Compared to 1 year ago, TESB has a worse debt to assets ratio.
TESB.BR Yearly Shares OutstandingTESB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
TESB.BR Yearly Total Debt VS Total AssetsTESB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.08 indicates that TESB is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.08, TESB perfoms like the industry average, outperforming 43.94% of the companies in the same industry.
  • TESB has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as TESB would need 2.34 years to pay back of all of its debts.
  • TESB's Debt to FCF ratio of 2.34 is amongst the best of the industry. TESB outperforms 90.91% of its industry peers.
  • TESB has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • TESB has a better Debt to Equity ratio (0.06) than 87.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Altman-Z 2.08
ROIC/WACC0.34
WACC7.28%
TESB.BR Yearly LT Debt VS Equity VS FCFTESB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • TESB has a Current Ratio of 1.94. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
  • TESB has a Current ratio of 1.94. This is in the better half of the industry: TESB outperforms 63.64% of its industry peers.
  • TESB has a Quick Ratio of 1.18. This is a normal value and indicates that TESB is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.18, TESB is in line with its industry, outperforming 59.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.18
TESB.BR Yearly Current Assets VS Current LiabilitesTESB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • TESB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.18%.
  • The earnings per share for TESB have been decreasing by -20.75% on average. This is quite bad
  • TESB shows a small growth in Revenue. In the last year, the Revenue has grown by 2.05%.
  • TESB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.72% yearly.
EPS 1Y (TTM)-131.18%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.97% on average over the next years. This is quite good.
  • Based on estimates for the next years, TESB will show a small growth in Revenue. The Revenue will grow by 3.77% on average per year.
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue Next Year1.98%
Revenue Next 2Y3.63%
Revenue Next 3Y3.79%
Revenue Next 5Y3.77%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TESB.BR Yearly Revenue VS EstimatesTESB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TESB.BR Yearly EPS VS EstimatesTESB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

  • TESB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 14.95 indicates a correct valuation of TESB.
  • Based on the Price/Forward Earnings ratio, TESB is valued a bit cheaper than 69.70% of the companies in the same industry.
  • TESB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.11.
Industry RankSector Rank
PE N/A
Fwd PE 14.95
TESB.BR Price Earnings VS Forward Price EarningsTESB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TESB is valued cheaply inside the industry as 92.42% of the companies are valued more expensively.
  • TESB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. TESB is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.12
EV/EBITDA 5.22
TESB.BR Per share dataTESB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • TESB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as TESB's earnings are expected to grow with 19.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.83%
EPS Next 3Y19.97%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.97%, TESB has a reasonable but not impressive dividend return.
  • TESB's Dividend Yield is comparable with the industry average which is at 2.21.
  • TESB's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.97%

5.2 History

  • The dividend of TESB is nicely growing with an annual growth rate of 6.16%!
Dividend Growth(5Y)6.16%
Div Incr Years0
Div Non Decr Years2
TESB.BR Yearly Dividends per shareTESB.BR Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • TESB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • TESB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-166.05%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
TESB.BR Yearly Income VS Free CF VS DividendTESB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

TESSENDERLO GROUP

EBR:TESB (3/2/2026, 7:00:00 PM)

26.3

-0.6 (-2.23%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)03-24
Inst Owners6.55%
Inst Owner ChangeN/A
Ins Owners67.43%
Ins Owner ChangeN/A
Market Cap1.55B
Revenue(TTM)2.75B
Net Income(TTM)-27.10M
Analysts76.36
Price Target27.54 (4.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.97%
Yearly Dividend0.88
Dividend Growth(5Y)6.16%
DP-166.05%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.95
P/S 0.57
P/FCF 14.12
P/OCF 5.38
P/B 0.87
P/tB 1
EV/EBITDA 5.22
EPS(TTM)-0.45
EYN/A
EPS(NY)1.76
Fwd EY6.69%
FCF(TTM)1.86
FCFY7.08%
OCF(TTM)4.89
OCFY18.58%
SpS46.5
BVpS30.17
TBVpS26.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.96%
ROE -1.52%
ROCE 3.29%
ROIC 2.47%
ROICexc 2.77%
ROICexgc 3.14%
OM 2.61%
PM (TTM) N/A
GM 19.33%
FCFM 4.01%
ROA(3y)5.03%
ROA(5y)5.73%
ROE(3y)8.04%
ROE(5y)10.34%
ROIC(3y)6.25%
ROIC(5y)7.52%
ROICexc(3y)6.83%
ROICexc(5y)8.71%
ROICexgc(3y)7.61%
ROICexgc(5y)9.79%
ROCE(3y)8.33%
ROCE(5y)10.06%
ROICexgc growth 3Y-43.17%
ROICexgc growth 5Y-19.86%
ROICexc growth 3Y-44.09%
ROICexc growth 5Y-20.16%
OM growth 3Y-39.29%
OM growth 5Y-20.88%
PM growth 3Y-43.63%
PM growth 5Y-21.76%
GM growth 3Y-9.65%
GM growth 5Y-5.01%
F-Score6
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 2.34
Debt/EBITDA 0.38
Cap/Depr 80.05%
Cap/Sales 6.5%
Interest Coverage 7.18
Cash Conversion 97.86%
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.18
Altman-Z 2.08
F-Score6
WACC7.28%
ROIC/WACC0.34
Cap/Depr(3y)86.45%
Cap/Depr(5y)81.94%
Cap/Sales(3y)5.77%
Cap/Sales(5y)5.54%
Profit Quality(3y)143.93%
Profit Quality(5y)139.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-131.18%
EPS 3Y-45.77%
EPS 5Y-20.75%
EPS Q2Q%-116.23%
EPS Next Y26.82%
EPS Next 2Y23.83%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue 1Y (TTM)2.05%
Revenue growth 3Y8.35%
Revenue growth 5Y8.72%
Sales Q2Q%7.08%
Revenue Next Year1.98%
Revenue Next 2Y3.63%
Revenue Next 3Y3.79%
Revenue Next 5Y3.77%
EBIT growth 1Y11.66%
EBIT growth 3Y-34.22%
EBIT growth 5Y-13.98%
EBIT Next Year252.49%
EBIT Next 3Y61.51%
EBIT Next 5Y41.73%
FCF growth 1Y88.36%
FCF growth 3Y0.11%
FCF growth 5Y5.75%
OCF growth 1Y37.1%
OCF growth 3Y10.33%
OCF growth 5Y8.69%

TESSENDERLO GROUP / TESB.BR FAQ

Can you provide the ChartMill fundamental rating for TESSENDERLO GROUP?

ChartMill assigns a fundamental rating of 4 / 10 to TESB.BR.


Can you provide the valuation status for TESSENDERLO GROUP?

ChartMill assigns a valuation rating of 5 / 10 to TESSENDERLO GROUP (TESB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for TESSENDERLO GROUP?

TESSENDERLO GROUP (TESB.BR) has a profitability rating of 3 / 10.


What is the earnings growth outlook for TESSENDERLO GROUP?

The Earnings per Share (EPS) of TESSENDERLO GROUP (TESB.BR) is expected to grow by 26.82% in the next year.


How sustainable is the dividend of TESSENDERLO GROUP (TESB.BR) stock?

The dividend rating of TESSENDERLO GROUP (TESB.BR) is 4 / 10 and the dividend payout ratio is -166.05%.